Sort by

Send to

Choose Destination

Links from PubMed

Items: 15


Biomarkers of risk to develop lung cancer in the new screening era.

Atwater T, Massion PP.

Ann Transl Med. 2016 Apr;4(8):158. doi: 10.21037/atm.2016.03.46. Review.


Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.

Wang X, Ma K, Chi L, Cui J, Jin L, Hu JF, Li W.

J Cancer. 2016 Apr 28;7(7):846-53. doi: 10.7150/jca.13437.


Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.

Marcus MW, Raji OY, Duffy SW, Young RP, Hopkins RJ, Field JK.

Int J Oncol. 2016 Jul;49(1):361-70. doi: 10.3892/ijo.2016.3499.


Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population.

Wang X, Jin L, Cui J, Ma K, Chen X, Li W.

Thorac Cancer. 2015 Jan;6(1):91-6. doi: 10.1111/1759-7714.12153.


Genetic test to stop smoking (GeTSS) trial protocol: randomised controlled trial of a genetic test (Respiragene) and Auckland formula to assess lung cancer risk.

Nichols JA, Grob P, de Lusignan S, Kite W, Williams P.

BMC Pulm Med. 2014 May 1;14:77. doi: 10.1186/1471-2466-14-77.


Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention.

Kathuria H, Gesthalter Y, Spira A, Brody JS, Steiling K.

Cancers (Basel). 2014 May 16;6(2):1157-79. doi: 10.3390/cancers6021157.


Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.

Wang X, Hu JF, Tan Y, Cui J, Wang G, Mrsny RJ, Li W.

PLoS One. 2014 May 2;9(5):e95915. doi: 10.1371/journal.pone.0095915.


Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.

Young RP, Hopkins RJ, Gamble GD.

Front Genet. 2012 Oct 16;3:210. doi: 10.3389/fgene.2012.00210.


Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium.

Brenner DR, Boffetta P, Duell EJ, Bickeböller H, Rosenberger A, McCormack V, Muscat JE, Yang P, Wichmann HE, Brueske-Hohlfeld I, Schwartz AG, Cote ML, Tjønneland A, Friis S, Le Marchand L, Zhang ZF, Morgenstern H, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Foretova L, Janout V, Bencko V, Schejbalova M, Brennan P, Mates IN, Lazarus P, Field JK, Raji O, McLaughlin JR, Liu G, Wiencke J, Neri M, Ugolini D, Andrew AS, Lan Q, Hu W, Orlow I, Park BJ, Hung RJ.

Am J Epidemiol. 2012 Oct 1;176(7):573-85.


The effect of metformin and thiazolidinedione use on lung cancer in diabetics.

Mazzone PJ, Rai H, Beukemann M, Xu M, Jain A, Sasidhar M.

BMC Cancer. 2012 Sep 14;12:410. doi: 10.1186/1471-2407-12-410.


Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.

Moghaddam SJ, Ochoa CE, Sethi S, Dickey BF.

Int J Chron Obstruct Pulmon Dis. 2011;6:113-23. doi: 10.2147/COPD.S15417. Review.


Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI).

Juliana F, Jardim JR, Fernandes AL, Jamnik S, Santoro IL.

Clinics (Sao Paulo). 2010;65(12):1247-51.


Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD.

Young RP, Hopkins RJ, Whittington CF, Hay BA, Epton MJ, Gamble GD.

PLoS One. 2011 Feb 3;6(2):e16476. doi: 10.1371/journal.pone.0016476.


Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?

Gordon LG, Hirst NG, Young RP, Brown PM.

Cost Eff Resour Alloc. 2010 Sep 16;8:18. doi: 10.1186/1478-7547-8-18.


The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.

Varella-Garcia M, Schulte AP, Wolf HJ, Feser WJ, Zeng C, Braudrick S, Yin X, Hirsch FR, Kennedy TC, Keith RL, Barón AE, Belinsky SA, Miller YE, Byers T, Franklin WA.

Cancer Prev Res (Phila). 2010 Apr;3(4):447-53. doi: 10.1158/1940-6207.CAPR-09-0165.

Items per page

Supplemental Content

Support Center